Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2024/08/072313
CTRI/2024/08/072313
Not yet recruiting
Phase 4

Evaluation of Optical Coherence Tomography Angiography Parameters Following Use of Ranibizumab Biosimilar in Branch Retinal Vein Occlusion. - NI

Maulana Azad Medical College0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
Maulana Azad Medical College
Status
Not yet recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • •1\. Treatment naïve patients in the age group of 45\-65 years having branch retinal vein occlusion of less than three months duration along with macular edema(Central foveal thickness of \=300 micrometers)
  • •2\. Subjects having best corrected visual acuity of at least 6/60

Exclusion Criteria

  • •1\. Patients having ocular conditions associated with accumulation of sub\-retinal fluid or macular affection like diabetic retinopathy, polypoidal choroidal vasculopathy (PCV), ocular inflammations, age\-related macular degeneration, pathologic myopia and angioid streaks
  • •2\. Patients who have undergone any intraocular surgery other than uncomplicated cataract extraction
  • •3\. Risk of thrombo\-embolic events and/or occurrence of these within past 6 months

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
evaluation of OCTA following antiVEGF in patient having retinal disease non resolving central serous chorioretinopathy
CTRI/2024/08/072312Maulana Azad Medical college
Not yet recruiting
Not Applicable
evaluation of OCTA following use of antiVEGF in retinal disease of eye in patients above 50 yrs
CTRI/2023/03/050175MAULANA AZAD MEDICAL COLLEGE
Not yet recruiting
Not Applicable
Evaluation of OCTA following use of Anti VEGF in retinal disease of eye in diabetic patientsHealth Condition 1: H350- Background retinopathy and retinalvascular changes
CTRI/2023/04/051257Maulana Azad Medical College
Recruiting
Not Applicable
Optical coherence tomography angiography in healthy subjects and patients with retinal vascular diseases.Retinal vascular diseases
ACTRN12617001633370lions eye institute300
Not yet recruiting
Not Applicable
Evaluation of OCTA parameters in CSCR
CTRI/2021/09/036966KAVYA C RAO